Influence of HLA-DRB-1 alleles on the production of antibody against CSP, MSP-1, AMA-1, and DBP in Brazilian individuals naturally infected with Plasmodium vivax

Acta Tropica

Volumn 121, Issue 2, 2012, Pages 152-155

  Storti Melo, Luciane Moreno ^a,b   da Costa, Daniela Reis ^b   Souza Neiras, Wanessa Christina ^b,c   Cassiano, Gustavo Capatti ^b,d   Couto, Vanja Suely Calvosa D'Almeida ^e   Póvoa, Marinete Marins ^f   Soares, Irene da Silva ^g   de Carvalho, Luzia Helena ^h   Arevalo Herrera, Myrian ⁱ   Herrera, Sócrates ⁱ   Rossit, Andrea Regina Baptista ^j   Cordeiro, José Antonio ^b   de Mattos, Luiz Carlos ^b   Machado, Ricardo Luiz Dantas ^b  

^a FEDERAL UNIVERSITY OF SERGIPE   (Brazil)

^b FACULDADE DE MEDICINA DE SÃO JOSÉ DO RIO PRETO   (Brazil)

^c FEDERAL UNIVERSITY OF TRIÂNGULO MINEIRO   (Brazil)

^d SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^e Núcleo Estadual do Amapá/CRDT ^*  (Brazil)

^f INSTITUTO EVANDRO CHAGAS   (Brazil)

^g UNIVERSITY OF SÃO PAULO   (Brazil)

^h INSTITUTO OSWALDO CRUZ   (Brazil)

ⁱ UNIVERSIDAD DEL VALLE   (Colombia)

^j FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

more..

Author keywords

Antibody response; HLA DRB1; Plasmodium vivax

Indexed keywords

APICAL MEMBRANE ANTIGEN 1; CIRCUMSPOROZOITE PROTEIN; DUFFY BINDING PROTEIN; HLA ANTIGEN CLASS 2; HLA DR1 ANTIGEN; HLA DR10 ANTIGEN; HLA DR2 ANTIGEN; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN; HLA DR5 ANTIGEN; HLA DR6 ANTIGEN; HLA DR7 ANTIGEN; HLA DR8 ANTIGEN; HLA DRB1 ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; MEROZOITE SURFACE PROTEIN 1; UNCLASSIFIED DRUG;

ALLELE; ANTIBODY; ANTIGEN; MALARIA; PUBLIC HEALTH;

ADULT; AMINO TERMINAL SEQUENCE; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; BRAZIL; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE FREQUENCY; GENOTYPE; HUMAN; IMMUNE RESPONSE GENE; PLASMODIUM VIVAX MALARIA;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; BRAZIL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE FREQUENCY; HLA-DRB1 CHAINS; HUMANS; IMMUNOGLOBULIN G; MALARIA, VIVAX; MIDDLE AGED; PLASMODIUM VIVAX;

BRAZIL;

PLASMODIUM VIVAX;

EID: 84855953107     PISSN: 0001706X     EISSN: 18736254     Source Type: Journal    
DOI: 10.1016/j.actatropica.2011.10.009     Document Type: Article

References (22)

1. Arévalo-Herrera M., Chitnis C., Herrera S. Current status of Plasmodium vivax vaccine. Hum. Vaccin. 2010, 6:124-132.
2. Banic D.M., Goldberg A.C., Pratt-Riccio L.R., Oliveira-Ferreira J., Santos F., Gras-Masse H., Camus D., Kalil J., Daniel-Ribeiro C.T. Human leukocyte antigen class II control of the immune response to p126-derived amino terminal peptide from Plasmodium falciparum. Am. J. Trop. Med. Hyg. 2002, 66:509-615.
3. Beeson J.G., Crabb B.S. Towards a vaccine against Plasmodium vivax malaria. PLoS Med. 2007, 4:e350.
4. Cerávolo I.P., Bruña-Romero O., Braga E.M., Fontes C.J., Brito C.F., Souza J.M., Krettli A.U., Adams J.H., Carvalho L.H. Anti-Plasmodium vivax duffy binding protein antibodies measure exposure to malaria in the Brazilian Amazon. Am. J. Trop. Med. Hyg. 2005, 72:675-681.
5. Duah N.O., Weiss H.A., Jepson A., Tetteh K.K.A., Whittle H.C., Conway D.J. Heritability of antibody isotype and subclass responses to Plasmodium falciparum antigens. PLoS One 2009, 4:e7381.
6. Garavito, G., 2003. Asociación HLA y Artritis Reumatoidea Juvenil: Em busca de las bases moleculares dependiente del MHC. Tesis Doctoral. Universidad del Norte, Colombia.
7. Germain R.N. Fundamental Immunology 1999, Lippincott-Raven, Philadelphia. 4th ed.
8. Good M.F., Xu H., Wykes M., Engwerda C.R. Development and regulation of cell-mediated immune responses to the blood stages of malaria: implications for vaccine research. Annu. Rev. Immunol. 2005, 23:69-99.
9. Herrera S., Bonelo A., Perlaza B.L., Fernández O.L., Victoria L., Lenis A.M., Soto L., Hurtado H., Acuña L.M., Vélez J.D., Palacios R., Chen-Mok M., Corradin G., Arévalo-Herrera M. Safety and elicitation of humoral and cellular responses in colombian malaria-naive volunteers by a Plasmodium vivax circumsporozoite protein-derived synthetic vaccine. Am. J. Trop. Med. Hyg. 2005, 73(S5):3-9.
10. Herrera S., Bonelo A., Perlaza B.L., Valencia A.Z., Cifuentes C., Hurtado S., Quintero G., López J.A., Corradin G., Arevalo-Herrera M. Use of long synthetic peptides to study the antigenicity and immunogenicity of the Plasmodium vivax circumsporozoite protein. Int. J. Parasitol. 2004, 34:1535-1546.
11. Johnson A.H., Leke R.G., Mendell N.R., Shon D., Suh Y.J., Bomba-Nkolo D., Tchinda V., Kouontchou S., Thuita L.W., Van der Wel A.M., Thomas A., Stowers A., Saul A., Zhou A., Taylor D.W., Quakyi L.A. Human leukocyte antigen class II alleles influence levels of antibodies to the Plasmodium falciparum asexual-stage apical membrane antigen 1 but not to merozoite surface antigen 2 and merozoite surface protein 1. Infect. Immun. 2004, 72:2762-2771.
12. Kimura M., Kneko O., Liu Q., Zhou M., Kawamoto F., Wataya Y., Otani S., Yamaguchi Y., Tanake K. Identification of the four species of human malaria parasites by nested PCR that targets variant sequences in the small subunit rRNA gene. Parasitol. Int. 1997, 46:91-95.
13. Nardin E.H., Calvo-Calle J.M., Oliveira G.A., Nussenzweig R.S., Schneider M., Tiercy J.M., Loutan L., Hochstrasser D., Rose K. A totally synthetic polyoxime malaria vaccine containing Plasmodium falciparum B cell and universal T cell epitopes elicits immune response in volunteers of diverse HLA types. J. Immunol. 2001, 166:481-489.
14. Nardin E.H., Oliveira G.A., Calvo-Calle J.M., Castro Z.R., Nussenzweig R.S., Schmeckpeper B., Hall B.F., Diggs C., Bodison S., Edelman R. Synthetic malaria peptide vaccine elicits high levels of antibodies in vaccines of defined HLA genotypes. J. Infect. Dis. 2000, 182:1486-1496.
15. Oliveira-Ferreira J., Pratt-Riccio L.R., Arruda M., Santos F., Ribeiro C.T., Goldberg A.C., Banic D.M. HLA class II and antibody responses to circumsporozoite protein repeats of P. vivax (VK210 VK247 and P. vivax-like) in individuals naturally exposed to malaria. Acta Trop. 2004, 92:63-69.
16. Parra-López C., Calvo-Calle J.M., Cameron T.O., Vargas L.E., Salazar L.M., Patarroyo M.E., Nardin E., Stern L.J. Major histocompatibility complex and T cell interactions of a universal T cell epitope from Plasmodium falciparum circumsporozoite protein. J. Biol. Chem. 2006, 281:14907-14917.
17. Penny M.A., Maire N., Studer A., Schapira A., Smith T.A. What should vaccine developers ask? Simulation of the effectiveness of malaria vaccines. PLoS One 2008, 11:e3193.
18. Remarque E.J., Faber B.W., Kocken C.H.M., Thomas A.W. Apical membrane antigen 1: a malaria vaccine candidate in review. Trends Parasitol. 2008, 24:74-84.
19. Rodrigues M.H., Rodrigues K.M., Oliveira T.R., Cômodo A.N., Rodrigues M.M., Kocken C.H., Thomas A.W., Soares I.S. Antibody response of naturally infected individuals to recombinant Plasmodium vivax apical membrane antigen-1. Int. J. Parasitol. 2005, 35:185-192.
20. Storti-Melo L.M., Souza-Neiras W.C., Cassiano G.C., Taveira L.C., Cordeiro J.A., Couto V.S.C.D., Póvoa M.M., Cunha M.G., Echeverry D.M., Rossit A.R.B., Herrera M.A., Herrera S., Machado R.L.D. Evaluation of the naturally-acquired antibody immune response to the Pv200L N-terminal fragment of Plasmodium vivax merozoite surface protein-1 in four areas of the Amazon Region of Brazil. Am. J. Trop. Med. Hyg. 2011, 84:58-63.
21. Valderrama-Aguirre A., Quintero G., Gómez A., Castellanos A., Pérez Y., Méndez F., Arévalo-Herrera M., Herrera S. Antigenicity, immunogenicity and protective efficacy of Plasmodium vivax MSP1 PV200L: a potential malaria vaccine subunit. Am. J. Trop. Med. Hyg. 2005, 73:16-24.
22. Zhang Q., Xue X., Xu X., Wang C., Chang W., Pan W. Influence of HLA-DRB1 alleles on antibody responses to PfCP-2.9-immunized and naturally infected individuals. J. Clin. Immunol. 2009, 29:454-460.